BioCentury | Apr 6, 2015
Company News

Catamaran, UnitedHealth Group other news

...The OptumRx Inc. pharmacy benefit manager unit of UnitedHealth will acquire fellow PBM Catamaran for $61.50...
...$61.50 per share in cash, or $12.8 billion. The price is a 27% premium to Catamaran’s...
...this year; CVS Health said in December it expected to process 1.1 billion claims annually. Catamaran...
BioCentury | Mar 31, 2015
Company News

OptumRx acquires Catamaran, consolidating PBMs

...OptumRx Inc., the pharmacy benefit manager unit of UnitedHealth Group Inc. (NYSE:UNH), will acquire Catamaran Corp. (NASDAQ:CTRX...
...about $0.30 per share in 2016. The parties expect to close the transaction in 4Q15. Catamaran...
...be president. Catamaran EVP of Operations Jeff Park will be COO of the merged company. Catamaran...
BioCentury | Mar 16, 2015
Strategy

Zarxio tea leaves

...closed formulary, we could only list the Sandoz drug." Sumit Dutta, SVP and CMO at Catamaran Corp....
...of dosing," Sherman told BioCentury. Dutta didn't say how the launch of Zarxio would affect Catamaran's...
...Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Apotex Inc., Toronto, Ontario Avalere Health LLC, Washington, D.C. Catamaran Corp....
BioCentury | Feb 9, 2015
Company News

Gilead, Catamaran, Cigna Corp. sales and marketing update

...inhibitor, and ledipasvir, an HCV NS5A protein . Catamaran declined to disclose pricing details. Separately, Catamaran...
...program for HCV through its BriovaRx specialty pharma. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Catamaran Corp....
BioCentury | Feb 5, 2015
Company News

HCV stocks fall after Gilead's discount signal

...patients with genotype 1, and Catamaran Corp. (NASDAQ:CTRX; TSX:CCT), which will offer Harvoni and Sovaldi. The Catamaran...
BioCentury | Jan 19, 2015
Strategy

Partitioning HCV

...lot at play and some have made public announcements and some have not," Chase added. Catamaran Corp....
...Ind. Blue Cross Blue Shield Association, Chicago, Ill. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Catamaran Corp....
BioCentury | Sep 1, 2014
Strategy

Back to School 2014: Paying the piper

...told BioCentury the regional insurer also plans to introduce a closed formulary option for 2015. Catamaran Corp....
...excluded drugs list in June, but the PBM did not include specialty drugs. For those, Catamaran...
...industry and payers already use to monitor things like adherence for specialty drugs. For example, Catamaran's...
BioCentury | Jun 9, 2014
Strategy

Guest Commentary: Cost steamroller

...products are now 30% of the total drug bill and, according to another big PBM, Catamaran Corp....
...American Society of Clinical Oncology (ASCO), Alexandria, Va. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Catamaran Corp....
BioCentury | Jun 2, 2014
Company News

Tesaro management update

...of Catalyst Health Solutions Inc. , which merged with SXC Health Solutions Corp. to form Catamaran Corp. WIR...
BioCentury | May 26, 2014
Strategy

Measured exclusion

...PBMs are cracking down on mounting specialty drug costs through tools like excluded drugs lists, Catamaran Corp....
...drugs list the PBM plans to release next month will not include specialty drugs. Instead, Catamaran...
...none of the companies Catamaran has approached have agreed so far. Companies and Institutions Mentioned Catamaran Corp....
Items per page:
1 - 10 of 14
BioCentury | Apr 6, 2015
Company News

Catamaran, UnitedHealth Group other news

...The OptumRx Inc. pharmacy benefit manager unit of UnitedHealth will acquire fellow PBM Catamaran for $61.50...
...$61.50 per share in cash, or $12.8 billion. The price is a 27% premium to Catamaran’s...
...this year; CVS Health said in December it expected to process 1.1 billion claims annually. Catamaran...
BioCentury | Mar 31, 2015
Company News

OptumRx acquires Catamaran, consolidating PBMs

...OptumRx Inc., the pharmacy benefit manager unit of UnitedHealth Group Inc. (NYSE:UNH), will acquire Catamaran Corp. (NASDAQ:CTRX...
...about $0.30 per share in 2016. The parties expect to close the transaction in 4Q15. Catamaran...
...be president. Catamaran EVP of Operations Jeff Park will be COO of the merged company. Catamaran...
BioCentury | Mar 16, 2015
Strategy

Zarxio tea leaves

...closed formulary, we could only list the Sandoz drug." Sumit Dutta, SVP and CMO at Catamaran Corp....
...of dosing," Sherman told BioCentury. Dutta didn't say how the launch of Zarxio would affect Catamaran's...
...Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Apotex Inc., Toronto, Ontario Avalere Health LLC, Washington, D.C. Catamaran Corp....
BioCentury | Feb 9, 2015
Company News

Gilead, Catamaran, Cigna Corp. sales and marketing update

...inhibitor, and ledipasvir, an HCV NS5A protein . Catamaran declined to disclose pricing details. Separately, Catamaran...
...program for HCV through its BriovaRx specialty pharma. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Catamaran Corp....
BioCentury | Feb 5, 2015
Company News

HCV stocks fall after Gilead's discount signal

...patients with genotype 1, and Catamaran Corp. (NASDAQ:CTRX; TSX:CCT), which will offer Harvoni and Sovaldi. The Catamaran...
BioCentury | Jan 19, 2015
Strategy

Partitioning HCV

...lot at play and some have made public announcements and some have not," Chase added. Catamaran Corp....
...Ind. Blue Cross Blue Shield Association, Chicago, Ill. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Catamaran Corp....
BioCentury | Sep 1, 2014
Strategy

Back to School 2014: Paying the piper

...told BioCentury the regional insurer also plans to introduce a closed formulary option for 2015. Catamaran Corp....
...excluded drugs list in June, but the PBM did not include specialty drugs. For those, Catamaran...
...industry and payers already use to monitor things like adherence for specialty drugs. For example, Catamaran's...
BioCentury | Jun 9, 2014
Strategy

Guest Commentary: Cost steamroller

...products are now 30% of the total drug bill and, according to another big PBM, Catamaran Corp....
...American Society of Clinical Oncology (ASCO), Alexandria, Va. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Catamaran Corp....
BioCentury | Jun 2, 2014
Company News

Tesaro management update

...of Catalyst Health Solutions Inc. , which merged with SXC Health Solutions Corp. to form Catamaran Corp. WIR...
BioCentury | May 26, 2014
Strategy

Measured exclusion

...PBMs are cracking down on mounting specialty drug costs through tools like excluded drugs lists, Catamaran Corp....
...drugs list the PBM plans to release next month will not include specialty drugs. Instead, Catamaran...
...none of the companies Catamaran has approached have agreed so far. Companies and Institutions Mentioned Catamaran Corp....
Items per page:
1 - 10 of 14